XML 37 R30.htm IDEA: XBRL DOCUMENT v3.25.2
Segments - Additional Information (Details)
6 Months Ended
Jun. 30, 2025
USD ($)
Segment
Jun. 30, 2024
USD ($)
Segment Reporting [Abstract]    
Number of operating segment | Segment 1  
Segment Reporting, Expense Information Used by CODM, Description The CODM assesses performance for the cardiovascular and pulmonary therapeutics segment and decides how to allocate resources based on net loss that also is reported on the income statement as consolidated net loss.  
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] srt:ChiefExecutiveOfficerMember, srt:PresidentMember  
Product revenue $ 0  
Net cash used in operating activities $ (13,230,000) $ (8,197,000)